Emersons Stock Surges 2.78% on Revised 1.1B Chloride Bid Ranked 271st in Trading Volume as Target Rejects Offer Shares Outpace Bid Price

Generated by AI AgentAinvest Volume Radar
Thursday, Sep 4, 2025 7:18 pm ET1min read
EMR--
Aime RobotAime Summary

- Emerson's stock surged 2.78% on 2025-09-04 amid a $1.1B renewed bid for Chloride Power, which rejected the offer as undervalued.

- Chloride shares rose to 295 pence, exceeding Emerson's 34% premium proposal, while emphasizing its standalone growth strategy since 2008.

- The rejected bid aligns with Emerson's data center expansion goals, though Chloride's global 15-country operations remain a key attraction.

Emerson (EMR) rose 2.78% on 2025-09-04, with a trading volume of $0.39 billion, up 46.47% from the previous day. The stock ranked 271st in trading volume among listed companies. The move followed Emerson’s renewed $1.1 billion bid for UK-based Chloride Power, a leading uninterruptible power supply (UPS) manufacturer. Chloride rejected the offer, citing undervaluation despite Emerson’s assertion that the proposal reflects a 34% premium to Chloride’s recent closing price. Chloride shares surged to 295 pence in early trading, surpassing the bid price.

Emerson emphasized that a merger would strengthen its global UPS market position, leveraging combined scale and customer relationships. The acquisition aligns with its strategy to expand in data center infrastructure and industrial markets. Chloride, however, highlighted its growth through organic and inorganic initiatives since 2008, asserting confidence in its standalone prospects. The bid mirrors past attempts, including a 2008 offer at 270 pence per share, which was also rebuffed. Chloride’s global presence, with operations across 15 countries, remains a key factor in Emerson’s interest.

Backtest results indicate no additional data was provided for analysis. The focus remains on the ongoing bid and its implications for Emerson’s market strategy.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet